An opportunity not to be missed – how do we improve postpartum screening rates for women with gestational diabetes?
Article first published online: 11 MAY 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Diabetes/Metabolism Research and Reviews
Volume 28, Issue 4, pages 312–316, May 2012
How to Cite
Keely, E. (2012), An opportunity not to be missed – how do we improve postpartum screening rates for women with gestational diabetes?. Diabetes Metab. Res. Rev., 28: 312–316. doi: 10.1002/dmrr.2274
- Issue published online: 11 MAY 2012
- Article first published online: 11 MAY 2012
- Accepted manuscript online: 6 JAN 2012 01:29PM EST
- Manuscript Accepted: 27 DEC 2011
- Manuscript Received: 16 DEC 2011
- gestational diabetes;
- postpartum screening;
The ability to detect postpartum dysglycaemia, intervene and prevent type 2 diabetes in this high-risk population may be the most compelling reason to diagnose gestational diabetes. However, most studies show that less than 50% of women receive any glucose screening in the postpartum period and are thus denied this opportunity. Although many have advocated for simpler testing, the 75-g oral glucose tolerance test remains the gold standard as fasting glucose level will miss 30–40% of cases of type 2 diabetes and will not detect isolated impaired glucose tolerance. Haemoglobin A1c as a screening test has not been adequately studied.
To improve postpartum screening rates, we need to increase awareness of the very high risk of type 2 diabetes, improve communication between providers, reduce fragmentation of care and introduce system factors that facilitate screening adherence. Copyright © 2012 John Wiley & Sons, Ltd.